Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
/PRNewswire/ -- Carisma Therapeutics Inc. (NASDAQ: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...